Dr. Loda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1300 York Avenue
Weill Cornell Medicine Pathology & Laboratory Medicine
New York, NY 10065
Education & Training
- Tufts Medical CenterResidency, Pathology-Anatomic and Clinical, 1988 - 1989
- Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Pathology-Anatomic and Clinical, 1986 - 1988
- University of Milan Faculty of MedicineClass of 1980
Certifications & Licensure
- NY State Medical License 2019 - 2026
- MA State Medical License 1988 - 2025
- American Board of Pathology Anatomic Pathology
Clinical Trials
- Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery Start of enrollment: 2003 May 27
Publications & Presentations
PubMed
- 67 citationsPrognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.Yoshifumi Baba, Katsuhiko Nosho, Kaori Shima, Jeffrey A. Meyerhardt, Andrew T. Chan
British Journal of Cancer. 2010-09-28 - 2101 citationsThe Molecular Taxonomy of Primary Prostate CancerAdam Abeshouse, Jaeil Ahn, Rehan Akbani, Adrian Ally, Samirkumar B. Amin
Cell. 2015-11-05 - 776 citationsGenomic correlates of clinical outcome in advanced prostate cancer.Wassim Abida, Joanna Cyrta, Glenn Heller, Davide Prandi, Joshua Armenia
Proceedings of the National Academy of Sciences of the United States of America. 2019-06-04
Press Mentions
- Silvia Formenti, Massimo Loda Elected to National Academy of MedicineOctober 22nd, 2024
- Drs. Silvia Formenti, Massimo Loda Elected to National Academy of MedicineOctober 21st, 2024
- Cancer Has Got a Lot of NerveAugust 12th, 2022
- Join now to see all
Grant Support
- Metabolic Syndrome, Fatty Acid Synthesis And Prostate CancerNational Cancer Institute2008–2011
- CA: Tissue And PathologyNational Cancer Institute2008–2011
- Tissue And Pathology ResourcesNational Cancer Institute2007–2011
- Pathology CoreNational Cancer Institute2007–2011
- Palmitoylation Signature In Prostate Cancer Cell LinesNational Center For Research Resources2010
- Core 3National Cancer Institute2007–2009
- Core--Tissue And PathologyNational Cancer Institute2002
- Core--PathologyNational Cancer Institute2001–2002
- Core--In Situ HybridizationNational Cancer Institute2000
- Core--Human Prostate Cancer PathologyNational Cancer Institute2000
- Isopeptidases Ubiquitin Degradation And Prostate CancerNational Cancer Institute1998–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: